[The use of naniprus in patients with myocardial infarct complicated by acute left ventricular failure].
A study of 64 patients indicates Naniprus is a highly-effective drug for control left ventricular failure. Intravenous administration of naniprus (15-30 mg 2 times daily) is effective in the prophylaxis of recurrences of left ventricular failure in patients with myocardial infarction.